Compare SOPH & HIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOPH | HIX |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.7M | 376.5M |
| IPO Year | 2021 | 1998 |
| Metric | SOPH | HIX |
|---|---|---|
| Price | $4.89 | $3.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 92.4K | ★ 368.5K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.58 | $3.75 |
| 52 Week High | $5.70 | $4.39 |
| Indicator | SOPH | HIX |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 46.49 |
| Support Level | $4.54 | $3.88 |
| Resistance Level | $5.31 | $4.27 |
| Average True Range (ATR) | 0.30 | 0.07 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 46.88 | 60.00 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.